b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" Owner="NLM">\n        <PMID Version="1">29974660</PMID>\n        <DateCompleted>\n            <Year>2019</Year>\n            <Month>05</Month>\n            <Day>01</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2019</Year>\n            <Month>05</Month>\n            <Day>01</Day>\n        </DateRevised>\n        <Article PubModel="Print-Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">1601-183X</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>18</Volume>\n                    <Issue>3</Issue>\n                    <PubDate>\n                        <Year>2019</Year>\n                        <Month>03</Month>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Genes, brain, and behavior</Title>\n                <ISOAbbreviation>Genes Brain Behav.</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Relationships between substance abuse/dependence and psychiatric disorders based on polygenic scores.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>e12504</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1111/gbb.12504</ELocationID>\n            <Abstract>\n                <AbstractText>Genetic susceptibility to substance use disorders (SUDs) is partially shared between substances. Heritability of any substance dependence, estimated as 54%, is partly explained by additive effects of common variants. Comorbidity between SUDs and other psychiatric disorders is frequent. The present study aims to analyze the additive role of common variants in this comorbidity using polygenic scores (PGSs) based on genome-wide association study discovery samples of schizophrenia (SCZ), bipolar disorder, attention-deficit/hyperactivity disorder, autism spectrum disorder, major depressive disorder and anxiety disorders, available from large consortia. PGSs were calculated for 534 patients meeting DSM-IV criteria for dependence of a substance and abuse/dependence of another substance between alcohol, tobacco, cannabis, cocaine, opiates, hypnotics, stimulants, hallucinogens and solvents; and 587 blood donors from the same population, Iberians from Galicia, as controls. Significance of the PGS and percentage of variance explained were calculated by logistic regression. Using discovery samples of similar size, significant associations with SUDs were detected for SCZ PGS. SCZ PGS explained more variance in SUDs than in most psychiatric disorders. Cross-disorder PGS based on five psychiatric disorders was significant after adjustment for the effect of SCZ PGS. SCZ PGS was significantly higher in women than in men abusing alcohol. Our findings indicate that SUDs share genetic susceptibility with SCZ to a greater extent than with other psychiatric disorders, including externalizing disorders such as attention-deficit/hyperactivity disorder. Women have lower probability to develop substance abuse/dependence than men at similar PGS probably because of a higher social pressure against excessive drug use in women.</AbstractText>\n                <CopyrightInformation>\xc2\xa9 2018 John Wiley &amp; Sons Ltd and International Behavioural and Neural Genetics Society.</CopyrightInformation>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Gurriar\xc3\xa1n</LastName>\n                    <ForeName>Xaqu\xc3\xadn</ForeName>\n                    <Initials>X</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Instituto de Investigaci\xc3\xb3n Sanitaria (IDIS) de Santiago de Compostela, Complexo Hospitalario Universitario de Santiago de Compostela (CHUS), Servizo Galego de Sa\xc3\xbade (SERGAS), Santiago de Compostela, Galicia, Spain.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Rodr\xc3\xadguez-L\xc3\xb3pez</LastName>\n                    <ForeName>Julio</ForeName>\n                    <Initials>J</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Instituto de Investigaci\xc3\xb3n Sanitaria (IDIS) de Santiago de Compostela, Complexo Hospitalario Universitario de Santiago de Compostela (CHUS), Servizo Galego de Sa\xc3\xbade (SERGAS), Santiago de Compostela, Galicia, Spain.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Fl\xc3\xb3rez</LastName>\n                    <ForeName>Gerardo</ForeName>\n                    <Initials>G</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Unidade de Conductas Adictivas, Servizo de Psiquiatr\xc3\xada, Complexo Hospitalario Universitario de Ourense (CHUO), Servizo Galego de Sa\xc3\xbade (SERGAS), Ourense, Galicia, Spain.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Pereiro</LastName>\n                    <ForeName>C\xc3\xa9sar</ForeName>\n                    <Initials>C</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Unidade Asistencial de Drogodependencias (ACLAD), A Coru\xc3\xb1a, Galicia, Spain.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Fern\xc3\xa1ndez</LastName>\n                    <ForeName>Jos\xc3\xa9 M</ForeName>\n                    <Initials>JM</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Unidade Asistencial de Drogodependencias, Ribeira, Galicia, Spain.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Fari\xc3\xb1as</LastName>\n                    <ForeName>Emilio</ForeName>\n                    <Initials>E</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Unidade Municipal de Atenci\xc3\xb3n a Drogodependientes (UMAD), Santiago de Compostela, Galicia, Spain.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Est\xc3\xa9vez</LastName>\n                    <ForeName>Valent\xc3\xadn</ForeName>\n                    <Initials>V</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Unidade de Conductas Adictivas, Servizo de Psiquiatr\xc3\xada, Complexo Hospitalario Universitario de Ourense (CHUO), Servizo Galego de Sa\xc3\xbade (SERGAS), Ourense, Galicia, Spain.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Arrojo</LastName>\n                    <ForeName>Manuel</ForeName>\n                    <Initials>M</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Instituto de Investigaci\xc3\xb3n Sanitaria (IDIS) de Santiago de Compostela, Complexo Hospitalario Universitario de Santiago de Compostela (CHUS), Servizo Galego de Sa\xc3\xbade (SERGAS), Santiago de Compostela, Galicia, Spain.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Servizo de Psiquiatr\xc3\xada, Complexo Hospitalario Universitario de Santiago de Compostela, Servizo Galego de Sa\xc3\xbade (SERGAS), Santiago de Compostela, Galicia, Spain.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Costas</LastName>\n                    <ForeName>Javier</ForeName>\n                    <Initials>J</Initials>\n                    <Identifier Source="ORCID">0000-0003-0306-3990</Identifier>\n                    <AffiliationInfo>\n                        <Affiliation>Instituto de Investigaci\xc3\xb3n Sanitaria (IDIS) de Santiago de Compostela, Complexo Hospitalario Universitario de Santiago de Compostela (CHUS), Servizo Galego de Sa\xc3\xbade (SERGAS), Santiago de Compostela, Galicia, Spain.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <CollectiveName>GenPol Study Group</CollectiveName>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n                <PublicationType UI="D013485">Research Support, Non-U.S. Gov\'t</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2018</Year>\n                <Month>07</Month>\n                <Day>19</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>England</Country>\n            <MedlineTA>Genes Brain Behav</MedlineTA>\n            <NlmUniqueID>101129617</NlmUniqueID>\n            <ISSNLinking>1601-183X</ISSNLinking>\n        </MedlineJournalInfo>\n        <CitationSubset>IM</CitationSubset>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D001523" MajorTopicYN="N">Mental Disorders</DescriptorName>\n                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008957" MajorTopicYN="Y">Models, Genetic</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D020412" MajorTopicYN="Y">Multifactorial Inheritance</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D011110" MajorTopicYN="N">Polymorphism, Genetic</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D019966" MajorTopicYN="N">Substance-Related Disorders</DescriptorName>\n                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>\n            </MeshHeading>\n        </MeshHeadingList>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="Y">SNP</Keyword>\n            <Keyword MajorTopicYN="Y">addiction</Keyword>\n            <Keyword MajorTopicYN="Y">genetic risk score</Keyword>\n            <Keyword MajorTopicYN="Y">genome-wide association studies</Keyword>\n            <Keyword MajorTopicYN="Y">polygenic risk score</Keyword>\n            <Keyword MajorTopicYN="Y">polygenic score</Keyword>\n            <Keyword MajorTopicYN="Y">psychiatric comorbidity</Keyword>\n            <Keyword MajorTopicYN="Y">schizophrenia</Keyword>\n            <Keyword MajorTopicYN="Y">substance abuse</Keyword>\n            <Keyword MajorTopicYN="Y">substance dependence</Keyword>\n            <Keyword MajorTopicYN="Y">substance use disorder</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2018</Year>\n                <Month>01</Month>\n                <Day>30</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="revised">\n                <Year>2018</Year>\n                <Month>06</Month>\n                <Day>20</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2018</Year>\n                <Month>07</Month>\n                <Day>02</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2018</Year>\n                <Month>7</Month>\n                <Day>6</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2019</Year>\n                <Month>5</Month>\n                <Day>2</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2018</Year>\n                <Month>7</Month>\n                <Day>6</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">29974660</ArticleId>\n            <ArticleId IdType="doi">10.1111/gbb.12504</ArticleId>\n        </ArticleIdList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'